Advertisement

M&A

Advertisement

Blue Cross and Blue Shield of Louisiana officials said they are again seeking to delay a regulatory hearing over its proposed sale to Elevance Health, nola.com reported Sept. 21. 

Centene is reportedly offloading its last U.K. businesses, continuing a strategy under CEO Sarah London of divesting from non-core businesses. 

Centene is planning to sell its Operose clinics in the U.K., its last remaining business in the country, the Financial Times reported Aug. 30. 

Advertisement